XYLTF Stock UPDATES Xylitol Cda Inc (XYLTF) 0.2491 09/13/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Xylitol Cda Inc (XYLTF) 0.2491 $XYLTF

Xylitol Canada Appoints Ian Sansom, P.Eng as Project Director: 21 Years of EPC/EPCM Experience to Benefit Company's Xylose Plant Project
Marketwire - Wed Aug 20, 8:06AM CDT
Xylitol Canada Inc. ("Xylitol Canada", or the "Company" (TSX VENTURE: XYL) today announced that it has engaged the services of Ian Sansom of EACL Consulting Services Inc. as the lead project manager overseeing the Company's plant development initiatives.

Xylitol Canada Inc. Reports 67% Six Month Revenue Growth Over Prior Year and Strategic Realignment
Marketwire - Tue Aug 12, 8:27AM CDT
Xylitol Canada Inc. (TSX VENTURE: XYL) reported revenues for its second quarter ended June 30, 2014 of approximately $2.0 Million, representing an increase of 43% over the same period from the preceding year. Gross margin performance for the quarter ended June 30, 2014 was 15.2%, compared to 32.0% for the same period of the preceding year. Several factors influenced the recent decline in gross margins, including an increased mix of lower margined sales, the addition of new bulk customers, and currency exchange rates. Operating results for the second quarter 2014 include a provision for restructuring expenses of approximately $200,000 related to asset write-downs, staff and contract termination costs, and other related expenses. Going forward, the Company will be working to improve gross margin levels to normalized industry standard by focusing on continued sales growth and continuing to implement measures that improve supply chain efficiencies.

Xylitol Canada Inc. Announces Results of Annual General and Special Meeting of Shareholders
Marketwire - Fri Jul 18, 2:42PM CDT
Xylitol Canada Inc. ("Xylitol Canada", or the "Company" (TSX VENTURE: XYL) is pleased to announce the successful completion of its annual general and special meeting held on July 17, 2014 (the "Meeting" .

Global Xylose Industry Report 2014-2019 with Focus on the Chinese Industry
M2 - Wed Jun 18, 7:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5m7c7c/global_and) has announced the addition of the "Global and Chinese Xylose Industry Report 2014" report to their offering. The Global and Chinese Xylose Industry Report 2014 is a professional and in-depth study on the current state of the global Xylose industry with a focus on the Chinese situation. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. Xylose market analysis is provided for both the international and Chinese domestic situations including development trends, competitive landscape analysis, key regions development status and a comparison analysis between the international and Chinese markets. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Xylose industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on 11 industry players providing information such as company profiles, product specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. Xylose industry development proposals and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. Key Topics Covered: - Xylose Industry Overview - Xylose International and China Market Analysis - Xylose Development Environmental Analysis - Xylose Development Policy and Plan - Xylose Manufacturing Process and Cost Structure - 2009-2014 Xylose Productions Supply Sales Demand Market Status and Forecast - Xylose Key Manufacturers Analysis - Up and Down Stream Industry Analysis - Xylose Marketing Channels Analysis - Xylose Industry Development Trend - Xylose Industry Development Proposals - Xylose New Project Investment Feasibility Analysis - Global and China Xylose Industry Research Conclusions Companies Mentioned - Chengdu Herbpurify Co. Ltd. - Danisco - Futaste - Hangzhou ShouXing Biotechnology Co. Ltd. - Healtang Biotech Co., Ltd - Huakang - Shandong Xieli - Shandong Longlive Bio-technology Co., Ltd. - Toyota Tsusho - Xylitol Canada Inc. - Yucheng Lujian Biological Technology Co., Ltd For more information visit http://www.researchandmarkets.com/research/5m7c7c/global_and

Xylitol Canada Inc. Announces Resignation of Director and Upcoming Reduction in Board Size
Marketwire - Wed Jun 18, 1:33AM CDT
Xylitol Canada Inc. ("Xylitol Canada", or the "Company" (TSX VENTURE: XYL) announced that Mr. Michael Boyd has resigned from the Board, effective June 12, 2014 in order to devote time to the requirements of his other business interests. The Board now consists of Mr. Thomas Kierans (Chairman), Mr. Pankaj Modi, Mr. Roger Daher, Mr. Brad Saville, Mr. Len Bykowski, Mr. Horst Heuniken and Mr. Andrew Reid (Xylitol Canada CEO). Messrs. Modi, Saville and Bykowski shall not be standing for re-election to the Board at its upcoming Annual General and Special Meeting of the Shareholders ("AGM" scheduled for July 17, 2014. On this basis and subject to approval at the AGM, the Company's Board shall then be comprised of four Directors, being Mr. Thomas Kierans, Mr. Roger Daher, Mr. Horst Heuniken and Mr. Andrew Reid.

Xylose Industry 2014 China & Global Development Trends Analysis Now Available at DeepResearchReports.com
PRWeb - Tue Jun 17, 11:31PM CDT
This is a professional and in-depth research report on Global and China Xylose industry. The report provides basic Xylose information, including Xylose definition, classification, application, and industry chain structure as well as industry overview. This research covers the international market analysis, including China's domestic market as well as global industry analysis covering macroeconomic environment & economic situation analysis. The report on China Xylose industry (http://www.deepresearchreports.com/111694.html) covers information on policy, plans for Xylose product specification, manufacturing process, product cost structure and much more. This report also provides statistics on key manufacturers in China and international market along with their Xylose production, cost, price, profit, production value, gross margin and other information. At the same time, information on these manufacturers also includes customer's application, capacity, market position and company contact information details. 2014 market research report on the Xylose industry also mentions data and information on capacity production, price, cost, profit, production value and gross margins of the market. The report lists Xylose upstream raw materials & equipment's as well as downstream client's alternative products, survey analysis, information on marketing channels as well as industry development trends and proposals.

Xylitol Canada Launches Online Marketing and Awareness Program via AGORACOM
Marketwire - Tue Feb 25, 8:05AM CST
XYLITOL CANADA(R) (TSX VENTURE: XYL) is pleased to announce an online marketing and awareness program through AGORA International Enterprises Corp. ("AGORACOM" .

Top Nutrition Resolution for 2014: Reduce Sugar Consumption
Marketwire - Wed Jan 01, 6:01AM CST
XYLITOL CANADA(R) (TSX VENTURE: XYL) -

Xylitol Canada Announces $3 Million Financing
Marketwire - Mon Sep 16, 4:24PM CDT
Xylitol Canada Inc. ("Xylitol Canada", or the "Company" (TSX VENTURE: XYL) is pleased to announce today that it has completed a $3 million debt financing (the "Loan" with Dundee Agricultural Corporation ("Dundee" . The Loan accrues interest at a rate of 1.0% per month. Subject to the approval of the TSX Venture Exchange (the "Exchange" and any shareholder approval which may be required by the Exchange, the principal amount of the Loan outstanding from time to time or any portion thereof may, at the option of Dundee, be converted into common shares of the Company at the price of $0.24 per common share. Upon conversion of the principal amount of the Loan, any accrued and unpaid interest up to but excluding the date of conversion will be paid in cash, or at the option of Dundee, and subject to the approval of the Exchange, in common shares at a price per share equal to the greater of: (a) the last closing price of the common shares on the Exchange on the date of conversion, and (b) $0.10 per share.

Xylitol Canada Inc. Financial Results for Three and Six Months Ended June 30, 2013
Marketwire - Mon Aug 19, 3:37PM CDT
Xylitol Canada Inc. ("Xylitol Canada", or the "Company" (TSX VENTURE: XYL) today announces that it has released its financial and operating results for the three and six months ended June 30, 2013. Highlights of the results include:

Xylitol Canada Announces Grant of Stock Options
Marketwire - Fri Aug 16, 3:16PM CDT
Xylitol Canada Inc. ("Xylitol Canada", or the "Company" (TSX VENTURE: XYL) announces today that pursuant to the terms of its stock option plan, the Company has granted an aggregate of 675,000 stock options to its directors, officers, employees and consultants. Each option entitles the holder thereof to purchase one common share of the Company at an exercise price of $0.30. The options are exercisable for a period of 5 years, subject to vesting restrictions over a period of nine (9) months.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Anthropic Bears Get New Tools, But Daily Risk Bites

Updated Category News Views 8

A $81.3 Billion Offering Invites Fast Money Anthropic arrived in public markets with the sort of numbers that make traders reach for both a calculator and a helmet. The company priced 980 million Class A shares at $83 on November 18, 2026, raising roughly $81.3 billion, then opened at $111.50 when it began Nasdaq trading on November 19. That is a monster debut by any...

Continue Reading
DKSH's Vietnam Oncology Pact Carries Real Promise, Risk

Updated Category News Views 5

A cancer-market announcement ought to make investors pause before they reach for a spreadsheet. Specialised Therapeutics and DKSH have signed an exclusive partnership to bring oncology therapies into Vietnam, and the human case is painfully clear: the country recorded an estimated 180,000 new cancer cases and more than 120,000 deaths annually in the 2022 GLOBOCAN data....

Continue Reading
Build-A-Bear Lawsuit Notice Carries a Date Problem

Updated Category News Views 39

Something is badly out of sequence in the Build-A-Bear shareholder alert, and that matters before anybody gets carried away by the legal boilerplate. The notice says investors who bought NYSE: BBW securities from March 28, 2026 through August 26, 2026 may be covered by a proposed federal securities class action. It also says the lead-plaintiff deadline is January 19,...

Continue Reading
Australia Leads TTW's 2027 Global Travel Country List

Updated Category News Views 43

A travel ranking is a map, not a balance sheet, and that distinction matters more than the glossy numbering. TTW has put Australia at the head of its editorial list of the 50 best countries to visit in 2027, followed by Switzerland, Japan, Canada and Thailand. Fair enough. Those are formidable tourism brands with the scenery, infrastructure and cultural pull to back up...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 445

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading

Top 5 Most Recently Viewed Articles

Amicus Therapeutics Plans Third Quarter 2025 Earnings Call

Updated Category News Views 159

Amicus Therapeutics to Discuss Q3 2025 Financial Results Amicus Therapeutics (NASDAQ: FOLD) is preparing for an important financial discussion as it will host a conference call on November 4, 2025, at 8:30 a.m. ET. This call aims to provide insights into the company’s financial performance for the quarter ending September 30, 2025. Conference Call Participation...

Continue Reading
Cineplex Inc. Hits New Milestones In Q2 2025 Financials

Updated Category News Views 223

Cineplex Reports Impressive Growth in Second Quarter Financials Cineplex Inc. (TSX: CGX) has announced its financial performance for the second quarter of 2025, revealing remarkable growth across various metrics. The company’s total revenues surged to CAD 361.8 million, representing a robust 30.5% increase compared to the same period last year. This performance can be...

Continue Reading
Pinnacle Mergers & Acquisitions Finalizes $151M Deal with Dream Motor Group

Updated Category News Views 545

Pinnacle Mergers & Acquisitions Completes a Major Sale DALLAS — Pinnacle Mergers & Acquisitions, a premier automotive buy-sell advisory firm, has finalized the significant sale of Toyota of Montgomery and Lexus of Montgomery to the renowned Dream Motor Group, led by famed coach Nick Saban and automotive expert Joe Agresti. The deal is valued at an impressive $151...

Continue Reading
Atria Development Corporation Appoints New Vice President

Updated Category News Views 80

Atria Development Corporation Welcomes New Leadership Atria Development Corporation is thrilled to announce that Durval Terceira has been appointed as the new Vice President of Business Development and Labour Relations. With his impressive background, he brings a wealth of experience that is expected to steer the company towards its future goals. Durval Terceira: An...

Continue Reading
Ark Invest's Strategic Shift: Selling Block Inc. Shares

Updated Category News Views 289

Ark Invest Adjusts Its Strategy Cathie Wood's Ark Invest has recently made headlines by selling off a portion of its holdings in Block Inc. This decision, valued at an impressive $4.8 million, signifies a potential shift in investment strategy ahead of Block's forthcoming earnings report. Investors are closely monitoring this move as it coincides with Block's rising...

Continue Reading